Dynamic changes in the structural characteristics of the postsynaptic membrane and, in particular, of dendritic spines have been a topic of great interest over the last decade (reviewed in refs.

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

A variety of antidotes have been reported to treat SSRI-induced sexual dysfunction effectively; however, virtually all the data on these agents are derived from open case reports and case series ...

Dolphins harass pufferfish and pass them around like a balloon... but the reason why is not what you might expect.

Hence, researchers often simulate the brain as a network of coupled neural masses, each described by a mean-field model. These models capture the essential features of neuronal populations while ...

Spiking Neural Networks (SNNs) have shown favorable performance recently. Nonetheless, the time-consuming computation on neuron level and complex optimization limit their real-time application.

In two publications presented as a contest, Hopfield and Brody propose a mechanism for detecting groups of neurons receiving similar levels of sensory input. The output neurons in Hopfield's and ...

USE ONAPGO is a prescription medicine used to treat motor fluctuations (OFF episodes) in adults with advanced Parkinson’s disease (PD). It is not known if ONAPGO is safe and effective in children.

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...